Using Neuroimaging to Study Cerebral Amyloid Angiopathy and Its Relationship to Alzheimer’s Disease
Journal of Alzheimer’s Disease · 2024
DOI: 10.3233/jad-230553 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Alzheimer’s Disease, 2024. Verfasst von Koral V Wheeler und 2 weiteren Autor:innen. Beteiligte Einrichtung: Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Ma…. Hauptthemen laut MEDLINE: Alzheimer Disease, Cerebral Amyloid Angiopathy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 277 Literaturangaben. Gefördert von: NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Cerebral amyloid angiopathy (CAA) is characterized by amyloid-β aggregation in the media and adventitia of the leptomeningeal and cortical blood vessels. CAA is one of the strongest vascular contributors to Alzheimer’s disease (AD). It frequently co-occurs in AD patients, but the relationship between CAA and AD is incompletely understood. CAA may drive AD risk through damage to the neurovascular unit and accelerate parenchymal amyloid and tau deposition. Conversely, early AD may also drive CAA through cerebrovascular remodeling that impairs blood vessels from clearing amyloid-β. Sole reliance on autopsy examination to study CAA limits researchers’ ability to investigate CAA’s natural disease course and the effect of CAA on cognitive decline. Neuroimaging allows for in vivo assessment of brain function and structure and can be leveraged to investigate CAA staging and explore its associations with AD. In this review, we will discuss neuroimaging modalities that can be used to investigate markers associated with CAA that may impact AD vulnerability including hemorrhages and microbleeds, blood-brain barrier permeability disruption, reduced cerebral blood flow, amyloid and tau accumulation, white matter tract disruption, reduced cerebrovascular reactivity, and lowered brain glucose metabolism. We present possible areas for research inquiry to advance biomarker discovery and improve diagnostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina Del Rey, CA, USA.
- Ethel Percy Andrus Gerontology Center, USC Leonard Davis School of Gerontology, University of Southern California, Los Angeles, CA, USA.
- Department of Biomedical Engineering, Corwin D. Denney Research Center, Viterbi School of Engineering, University of Southern California, Los Angeles, CA, USA.
Förderung
- NIA NIH HHS
Zitieren
APA
Wheeler, K. V., Irimia, A., & Braskie, M. N. (2024). Using Neuroimaging to Study Cerebral Amyloid Angiopathy and Its Relationship to Alzheimer’s Disease. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-230553
Vancouver
Wheeler KV, Irimia A, Braskie MN. Using Neuroimaging to Study Cerebral Amyloid Angiopathy and Its Relationship to Alzheimer’s Disease. Journal of Alzheimer’s Disease. 2024. doi:10.3233/jad-230553
BibTeX
@article{Wheeler2024,
author = {Wheeler, Koral V and Irimia, Andrei and Braskie, Meredith N},
title = {Using Neuroimaging to Study Cerebral Amyloid Angiopathy and Its Relationship to Alzheimer’s Disease},
journal = {Journal of Alzheimer’s Disease},
year = {2024},
doi = {10.3233/jad-230553}
}
EUVIMED